European lung cancer initiative: focus on early detection and effective treatment
A European Commission plan aims to improve early cancer detection and treatment. Could lung cancer patients also benefit from this?
You can be symptom-free and yet seriously ill: Globally, lung cancer is the second most common cancer and the deadliest. The lack of clear symptoms in the early stages means it is often detected too late. Early detection strategies are key, but this is a type of cancer that challenges medicine and health policy alike. We paid a visit to Professor Felix Herth, head of the Heidelberg University Hospital thorax clinic.
Urgent need for early detection
Complex package with open questions
Current standard, possible perspectives
Successful early detection thanks to lung cancer screening
Robert Koch-Institut, Zentrum für Krebsregisterdaten, https://www.krebsdaten.de/Krebs/DE/Content/Krebsarten/Lungenkrebs/lungenkrebs_node.html.
Deutsche Krebsgesellschaft: ONKO-Internetportal, https://www.krebsgesellschaft.de/onko-internetportal/onko-internetportal.html
Ärzte Zeitung, 20.4.2021
Europäische Kommission, Pressemitteilung 3.2.21, https://ec.europa.eu/commission/presscorner/detail/en/ip_21_342
Europäische Kommission, https://ec.europa.eu/info/strategy/priorities-2019-2024/promoting-our-european-way-life/european-health-union/cancer-plan-europe_de#latest
Knight, S.B. et al. Progress and prospects of early detection in lung cancer. Open Biol. 2017 Sep; 7(9): 170070. doi: 10.1098/rsob.170070
- Courtesy of Erlangen University Hospital, Erlangen, Germany
- The statements by Siemens Healthineers customers described herein are based on results that were achieved in the customer’s unique setting. Since there is no “typical” hospital and many variables exist (e.g., hospital size, case mix, level of IT adoption) there can be no guarantee that other customers will achieve the same results.